The intended target and the selected replacement fluid both influence the result. A less concentrated solution increases the plasma water fraction, but the clinical effect also depends on whether the goal is fluid and volume management or reduction of soluble substances such as antibodies and inflammatory mediators. Fluid selection therefore must be considered alongside electrolyte, coagulation, and hemodynamic status.
Adding replacement fluid changes plasma concentration by increasing the water fraction, whereas plasmapheresis selectively removes plasma components before restoring circulating volume. These approaches can therefore differ in which substances are removed and how volume is restored. The distinction matters when the clinical objective involves lowering circulating antibodies, inflammatory mediators, or another soluble plasma substance.
Electrolyte balance, coagulation status, and hemodynamic condition can all affect the clinical value of the approach. Dilution changes the concentration of plasma constituents, while plasma removal and replacement may alter the composition of circulating fluid. Consequently, the same strategy may have different implications depending on the patient’s existing fluid status and blood-related parameters.
When plasmapheresis is used, plasma is first removed selectively, and circulating volume is then restored with a replacement fluid. The available replacement categories described for this purpose are crystalloid, colloid, and donor plasma. Choosing among them should reflect the substances being targeted and the patient’s electrolyte, coagulation, and hemodynamic status.
Its medical uses center on fluid and volume management and on lowering circulating concentrations of soluble plasma substances. Depending on the clinical objective, those substances may include antibodies, inflammatory mediators, or other soluble factors. The approach is therefore relevant when both restoration of circulating volume and modification of plasma composition are important considerations.
The process can increase the plasma water fraction, restore circulating volume after plasma removal, and reduce concentrations of selected soluble substances. However, these outcomes are not independent of treatment conditions. The fluid used, the substance targeted, and the patient’s electrolyte, coagulation, and hemodynamic status determine how clinically useful the intervention will be.